Mary Gospodarowicz, MD, FRCPC, FRCR (Hon.) FASTRO

Mary Gospodarowicz is the Medical Director of the Cancer Program at Princess Margaret Hospital and University Health Network and the Regional Vice President of Cancer Care Ontario. She is also the Professor and Chair of the Department of Radiation Oncology at the University of Toronto and Chief of the Radiation Medicine Program at Princess Margaret Hospital.

She received her MD degree from the University of Toronto and holds specialty certifications in internal medicine, medical oncology and radiation oncology. She is an honorary Fellow of the Royal College of Radiologists in the United Kingdom, an honorary member of the European Society of Therapeutic Radiology and Oncology (ESTRO), a Fellow of the American Society of Therapeutic Radiology and Oncology (ASTRO) and past president of the Canadian Association of Radiation Oncologists (CARO). She is engaged in active clinical practice of radiation oncology treating patients with malignant lymphomas and genitourinary cancers. Her research interests include clinical trials evaluating the role of radiation therapy in lymphomas, prostate cancer, bladder cancer, and testis cancer. Currently, her interests are in developing and implementing image guided precision radiotherapy, late effects research, survivorship programs and research. She has a major interest in cancer staging and prognostic factor classification.

She is a past Chair of the Canadian Committee on Cancer Staging and currently chairs the Task Force on Prognostic Factors for the International Union Against Cancer (UICC) TNM Committee. Currently, she also chairs the UICC Task Force on Prognostic Factors. In the past 10 years she has co-edited three books on Prognostic Factors in Cancer, the newest published for the 2006 UICC World Cancer Congress. She initiated programs through the UICC to actively promote e-initiatives to raise the standard of cancer care worldwide. Mary Gospodarowicz has served on various provincial, national and international committees. She is member of the Board of Directors of UICC and the Chair of its Membership Committee. UICC is an international non-governmental organization dedicated to the global control of cancer. In addition, she is a member of the Board of Directors of the International Extranodal Lymphoma Study Group, the Scientific Advisory Boards of the Lymphoma Foundation of Canada.